Genetic burden in multiple sclerosis families

Genes and Immunity

Volumn 14, Issue 7, 2013, Pages 434-440

  Isobe, N ^a   Damotte, V ^a,b   Lo Re, V ^c   Ban, M ^c   Pappas, D ^a   Guillot Noel, L ^b   Rebeix, I ^b   Compston, A ^c   Mack, T ^d   Cozen, W ^d   Fontaine, B ^b   Hauser, S L ^a   Oksenberg, J R ^a   Sawcer, S ^c   Gourraud, P A ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^c UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^d UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

family study; genetic risk; multiple sclerosis

Indexed keywords

ADULT; ARTICLE; CONTROLLED STUDY; FAMILIAL DISEASE; FEMALE; GENE LOCUS; GENETIC ANALYSIS; GENETIC MARKER; GENETIC RISK; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIPLE SCLEROSIS; PRIORITY JOURNAL; RELAPSE; RELATIVE; SIBLING; SINGLE NUCLEOTIDE POLYMORPHISM; TWINS;

ADULT; CASE-CONTROL STUDIES; FEMALE; GENETIC LOAD; GENETIC LOCI; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MALE; MIDDLE AGED; MULTIPLE SCLEROSIS; PEDIGREE; POLYMORPHISM, SINGLE NUCLEOTIDE;

EID: 84886727488     PISSN: 14664879     EISSN: 14765470     Source Type: Journal    
DOI: 10.1038/gene.2013.37     Document Type: Article

References (29)

1. Oksenberg JR, Baranzini SE, Sawcer S, Hauser SL. The genetics of multiple sclerosis: SNPs to pathways to pathogenesis. Nat Rev Genet 2008; 9: 516-526.
2. Bush WS, Sawcer SJ, de Jager PL, Oksenberg JR, McCauley JL, Pericak-Vance MA et al. Evidence for polygenic susceptibility to multiple sclerosis-the shape of things to come. Am J Hum Genet 2010; 86: 621-625.
3. Gourraud PA, Harbo HF, Hauser SL, Baranzini SE. The genetics of multiple sclerosis: An up-to-date review. Immunol Rev 2012; 248: 87-103.
4. Sawcer S, Hellenthal G, Pirinen M, Spencer CC, Patsopoulos NA, Moutsianas L et al. Genetic risk and a primary role for cell-mediated immune mechanisms in multiple sclerosis. Nature 2011; 476: 214-219.
5. Burton PR, Clayton DG, Cardon LR, Craddock N, Deloukas P, Duncanson A et al. Association scan of 14, 500 nonsynonymous SNPs in four diseases identifies autoimmunity variants. Nat Genet 2007; 39: 1329-1337.
6. Hafler DA, Compston A, Sawcer S, Lander ES, Daly MJ, De Jager PL et al. Risk alleles for multiple sclerosis identified by a genomewide study. N Engl J Med 2007; 357: 851-862.
7. Comabella M, Craig DW, Camina-Tato M, Morcillo C, Lopez C, Navarro A et al. Identification of a novel risk locus for multiple sclerosis at 13q31.3 by a pooled genome-wide scan of 500, 000 single nucleotide polymorphisms. PLoS One 2008; 3: E3490.
8. ANZGENE-consortium. Genome-wide association study identifies new multiple sclerosis susceptibility loci on chromosomes 12 and 20. Nat Genet 2009; 41: 824-828.
9. Baranzini SE, Wang J, Gibson RA, Galwey N, Naegelin Y, Barkhof F et al. Genome-wide association analysis of susceptibility and clinical phenotype in multiple sclerosis. Hum Mol Genet 2009; 18: 767-778.
10. De Jager PL, Jia X, Wang J, de Bakker PI, Ottoboni L, Aggarwal NT et al. Meta-analysis of genome scans and replication identify CD6, IRF8 and TNFRSF1A as new multiple sclerosis susceptibility loci. Nat Genet 2009; 41: 776-782.
11. Jakkula E, Leppa V, Sulonen AM, Varilo T, Kallio S, Kemppinen A et al. Genome-wide association study in a high-risk isolate for multiple sclerosis reveals associated variants in STAT3 gene. Am J Hum Genet 2010; 86: 285-291.
12. Nischwitz S, Cepok S, Kroner A, Wolf C, Knop M, Muller-Sarnowski F et al. Evidence for VAV2 and ZNF433 as susceptibility genes for multiple sclerosis. J Neuroimmunol 2010; 227: 162-166.
13. Sanna S, Pitzalis M, Zoledziewska M, Zara I, Sidore C, Murru R et al. Variants within the immunoregulatory CBLB gene are associated with multiple sclerosis. Nat Genet 2010; 42: 495-497.
14. Baranzini SE, Galwey NW, Wang J, Khankhanian P, Lindberg R, Pelletier D et al. Pathway and network-based analysis of genome-wide association studies in multiple sclerosis. Hum Mol Genet 2009; 18: 2078-2090.
15. Cotsapas C, Voight BF, Rossin E, Lage K, Neale BM, Wallace C et al. Pervasive sharing of genetic effects in autoimmune disease. PLoS Genet 2011; 7: E1002254.
16. Rioux JD, Goyette P, Vyse TJ, Hammarstrom L, Fernando MM, Green T et al. Mapping of multiple susceptibility variants within the MHC region for 7 immunemediated diseases. Proc Natl Acad Sci USA 2009; 106: 18680-18685.
17. Couturier N, Bucciarelli F, Nurtdinov RN, Debouverie M, Lebrun-Frenay C, Defer G et al. Tyrosine kinase 2 variant influences T lymphocyte polarization and multiple sclerosis susceptibility. Brain 2011; 134(Pt 3): 693-703.
18. De Jager PL, Baecher-Allan C, Maier LM, Arthur AT, Ottoboni L, Barcellos L et al. The role of the CD58 locus in multiple sclerosis. Proc Natl Acad Sci USA 2009; 106: 5264-5269.
19. Gregory AP, Dendrou CA, Attfield KE, Haghikia A, Xifara DK, Butter F et al. TNF receptor 1 genetic risk mirrors outcome of anti-TNF therapy in multiple sclerosis. Nature 2012; 488: 508-511.
20. Gregory SG, Schmidt S, Seth P, Oksenberg JR, Hart J, Prokop A et al. Interleukin 7 receptor alpha chain (IL7R) shows allelic and functional association with multiple sclerosis. Nat Genet 2007; 39: 1083-1091.
21. Maier LM, Lowe CE, Cooper J, Downes K, Anderson DE, Severson C et al. IL2RA genetic heterogeneity in multiple sclerosis and type 1 diabetes susceptibility and soluble interleukin-2 receptor production. PLoS Genet 2009; 5: E1000322.
22. De Jager PL, Chibnik LB, Cui J, Reischl J, Lehr S, Simon KC et al. Integration of genetic risk factors into a clinical algorithm for multiple sclerosis susceptibility: A weighted genetic risk score. Lancet Neurol 2009; 8: 1111-1119.
23. Gourraud PA, McElroy JP, Caillier SJ, Johnson BA, Santaniello A, Hauser SL et al. Aggregation of multiple sclerosis genetic risk variants in multiple and single case families. Ann Neurol 2011; 69: 65-74.
24. Sawcer S, Ban M, Wason J, Dudbridge F. What role for genetics in the prediction of multiple sclerosis? Ann Neurol 2010; 67: 3-10.
25. Patsopoulos NA, Esposito F, Reischl J, Lehr S, Bauer D, Heubach J et al. Genomewide meta-analysis identifies novel multiple sclerosis susceptibility loci. Ann Neurol 2011; 70: 897-912.
26. Lango Allen H, Estrada K, Lettre G, Berndt SI, Weedon MN, Rivadeneira F et al. Hundreds of variants clustered in genomic loci and biological pathways affect human height. Nature 2010; 467: 832-838.
27. Barcellos LF, Oksenberg JR, Green AJ, Bucher P, Rimmler JB, Schmidt S et al. Genetic basis for clinical expression in multiple sclerosis. Brain 2002; 125(Pt 1): 150-158.
28. Goodkin DE, Doolittle TH, Hauser SS, Ransohoff RM, Roses AD, Rudick RA. Diagnostic criteria for multiple sclerosis research involving multiply affected families. Arch Neurol 1991; 48: 805-807.
29. Johnson AD, Handsaker RE, Pulit SL, Nizzari MM, O'Donnell CJ, de Bakker PI. SNAP: A web-based tool for identification and annotation of proxy SNPs using HapMap. Bioinformatics 2008; 24: 2938-2939.